2013 Medtech M&A Review

By Clyde A. Burkhardt

In 2013, as in 2012, there were a substantial number of mergers and acquisitions in the medical device and diagnostic industry. HT Capital Advisors tracked almost 180 medtech transactions in the first 10 months of 2013, compared with 230 tracked for all of 2012.

Transactions were made in most sectors of the industry as well as across international borders. As in past years, pharmaceutical companies were active both in acquiring and selling medtech companies. Private equity investors continued their significant involvement in medtech by both selling and acquiring companies to establish medtech platforms. There was also a substantial amount of divestiture activity as several major medtech companies sold operations outside the realm of their core business.

Read on for more on the following 2013 megers and acquistions in medtech:

The Biggest Deal of the Year: Thermo Fisher Scientific Acquires Life Technologies

Eye-Popping Vision Care Transactions

Bayer AG Conceives the Acquisition of Conceptus

A Big Dialysis Deal for Baxter International

Major Wound Care Transactions

Medtronic Acquires a Disease Management Company

A Lot of M&A Movement in Orthopedics

Another Active M&A Year for Boston Scientific

St. Jude Medical Jolts the Heart Care Sector with Two Acquisitions

Several Notable Diagnostics Transactions

3 Aesthetic-Focused Transactions

Conclusion and Future Outlook

Clyde A. Burkhardt is senior managing director of HT Capital Advisors LLC (New York City), a private investment banking firm. He leads HT Capital Advisors' groups focusing on the medical device, healthcare services, and precision component industries. Contact Burkhardt at [email protected].